PATENT CLAIM ANALYSIS

Application Number: 15923139
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["424", "450000"]

Abstract:
A “nanolipogel” is a delivery vehicle including one or more lipid layer surrounding a hydrogel core, which may include an absorbent such as a cyclodextrin or ion-exchange resin. Nanolipogels can be constructed so as to incorporate a variety of different chemical entities that can subsequently be released in a controlled fashion. These different incorporated chemical entities can differ dramatically with respect to size and composition. Nanolipogels have been constructed to contain co-encapsulated proteins as well as small hydrophobic drugs within the interior of the lipid bilayer. Agents incorporated within nanolipogels can be released into the milieu in a controlled fashion, for example, nanolipogels provide a means of achieving simultaneous sustained release of agents that differ widely in chemical composition and molecular weight. Additionally, nanolipogels can favorably modulate biodistribution.

Claim (Index 32):
The nanolipogel of  claim 17 , wherein the first active agent is a TGF-beta inhibitor and the additional active agent is IL-2.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 90.0
- Lexical Diversity: 1.57303
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14394161', '14394147', '15434971', '14537541', '15752008']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8028899677602135
- 35 USC 102 Novelty (BERT): 0.6582355609023501
- Combined Prediction Score: 0.7884245270744272
- Mean Citation Score: 472.26945799999993
- Max Citation Score: 740.7355299999997
- Similarity Product: 519.4575802605501

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test